NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Hydrochlorothiazide and Lithium: what the published research says

PubMed indexes 8 records that name Hydrochlorothiazide and Lithium together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Hydrochlorothiazide and Lithium. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Hydrochlorothiazide and Lithium.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Comparison of the effects of hydrochlorothiazide and furosemide on lithium disposition.

The American journal of psychiatry · 1991 · PMID 1853956

Clinical TrialComparative StudyRandomized Controlled Trial

“The observed differences between diuretics in effects on serum lithium may have been due to differences in the potency of the diuretics at the doses studied as well as in the site of action of the diuretic effect. The results must be interpreted cautiously, however, because the effects were small and of questionable clinical significance, and the study used healthy volunteers and low doses of lithium instead of psychiatric patients and the usual therapeutic levels of lithium.”

Crabtree et al. · Authors' conclusion

Names both Hydrochlorothiazide and Lithium in its title.

Lithium toxicity induced by triamterene-hydrochlorothiazide.

Postgraduate medical journal · 1980 · PMID 7267481

Case ReportsHuman subjects

“Reduced clearance of lithium has been reported to follow its concurrent administration with diuretics that deplete both sodium and potassium. A combination of triamterene with thiazide has not been shown previously to precipitate lithium toxicity.”

Mehta et al. · From the abstract

Names both Hydrochlorothiazide and Lithium in its title.

Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.

American journal of physiology. Renal physiology · 2014 · PMID 24352504

Animal study

“HCTZ treatment further resulted in reduced blood Li levels, creatinine clearance, and alkalinized urinary pH. Our in vitro and in vivo data indicate that part of the antidiuretic effect of HCTZ in Li-NDI is NCC independent and may involve a tubuloglomerular feedback response-mediated reduction in glomerular filtration rate due to proximal tubular carbonic anhydrase inhibition.”

Sinke et al. · From the abstract

Names both Hydrochlorothiazide and Lithium in its title.

Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.

Journal of the American Society of Nephrology : JASN · 2004 · PMID 15504936

Animal study

“Notably, HCTZ treatment induced a shift in molecular weight of gamma-epithelial sodium channel from 85 to 70 kD, consistent with previously demonstrated aldosterone stimulation. The upregulation of AQP2 and distal renal Na(+) transporters in response to HCTZ treatment may account for the antidiuretic action of HCTZ in NDI.”

Kim et al. · From the abstract

Names both Hydrochlorothiazide and Lithium in its title.

Effects of long-term administration of lithium and hydrochlorothiazide in rats.

Metal-based drugs · 1999 · PMID 18475886

“The histopathological examination of all the investigated organs: kidney, liver, brain and spleen, revealed significant lesions which were time-dependant and more pronounced in the association group. Although the changes were mostly inflammatory and conqestive, it was proved that the concomitant administration of lithium and hydrochlorothiazid is potentially dangerous, increasing lithium's nephrotoxicity and the thiazide diuretic's hepatotoxicity.”

Loghin et al. · From the abstract

Names both Hydrochlorothiazide and Lithium in its title.

Effects of perindopril and hydrochlorothiazide on the long-term progression of lithium-induced chronic renal failure in rats.

Pharmacology & toxicology · 1997 · PMID 9101586

Animal study

“The failure of effective antihypertensive treatment with an angiotension-converting enzyme inhibitor to modify the progression suggests that in this model, systemic or glomerular hypertension may not be an important pathophysiological factor. The structural and functional deterioration observed in Li-uraemic rats during treatment with hydrochlorothiazide remains unexplained.”

Christensen et al. · From the abstract

Names both Hydrochlorothiazide and Lithium in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Hydrochlorothiazide, Lithium, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.